• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2026 ABC News
  • Wellness

Obese Unlikely to Get Heart Transplants

ByCHARLES BANKHEAD, MedPage Today Staff Writer
September 17, 2010, 4:29 PM

Sept. 19, 2010— -- Morbidly obese patients with advanced heart failure rarely lose enough weight to qualify for heart transplantation, making ventricular assist devices destination therapy for many of them, researchers said.

Left ventricular assist devices (LVADs) provided adequate circulatory support as obese patients tried to qualify for heart transplants. The patients had a mean body mass index (BMI) of 39, which fell below that value in only a few cases during a year of follow-up, Dr. Jerry Estep reported here at the Heart Failure Society of America meeting.

Among patients who survived to one year, the mean BMI exceeded the baseline value.

Read this story on www.medpagetoday.com.

"Providing obese patients with [circulatory] support did not lead to weight loss," Estep, who practices at the Methodist Hospital in Houston told MedPage Today. "It's pretty obvious that long-term strategies for weight loss are needed to help obese patients with advanced heart failure lose weight and qualify for transplants."

Obesity increases the risk of heart failure and leads to worse outcomes after heart transplantation. As a result, many transplant centers have established a BMI cutoff of 35, said Estep. Patients whose BMI exceeds that level must lose sufficient weight to make the cutoff, even if they otherwise would qualify for transplantation.

Obese heart failure patients often receive LVADs during the period when they try to lose weight, but their impact on weight loss had not been studied extensively, and Estep and colleagues sought to fill some of the data gap.

Their review showed that 13 of 108 LVAD implantations over a six-year period involved morbidly obese patients (BMI =35). Of those 13 -- whose BMI averaged 38.8 -- eight received devices that provided continuous support and five got devices that provided pulsatile support. All 13 had New York Heart Association (NYHA) class IV heart failure at implantation.

The LVADs achieved the desired circulatory support, as the patients' mean functional class improved to NYHA class II at six months.

Up Next in Wellness—

Former White House COVID-19 response coordinator answers hantavirus questions

May 8, 2026

Many Medicare enrollees can get GLP-1 drugs for $50 starting in July

May 7, 2026

Online platform agrees to stop selling GLP-1 drugs to US customers

May 6, 2026

Parents of baby boy who was 'born twice' speak out

May 4, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2026 ABC News